Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

被引：0
作者：
Hirsch Matani
Divya Sahu
Michael Paskewicz
Anastasia Gorbunova
Ashten N. Omstead
Rodney Wegner
Gene G. Finley
Blair A. Jobe
Ronan J. Kelly
Ali H. Zaidi
Ajay Goel
机构：
[1] Allegheny Health Network Cancer Institute,Division of Radiation Oncology
[2] Beckman Research Institute of City of Hope,Department of Molecular Diagnostics and Experimental Therapeutics
[3] Allegheny Health Network,Esophageal and Lung Research
[4] Charles A. Sammons Cancer Center,Department of Hematology and Oncology
[5] Baylor University Medical Center,undefined
来源：
Biomarker Research | / 10卷
关键词：
Esophageal adenocarcinoma; Risk stratification; CROSS regimen; EPHA5; BCL6; ERBB2; Predict response; Prognostic classifier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Evaluating the feasibility and predictive accuracy of biodynamic imaging to platinum-based chemotherapy response in esophageal adenocarcinoma [J].
Ajrouch, Ali ;
Krempley, Ben ;
Karkash, Ahmad ;
Dewitt, John M. ;
Al-Haddad, Mohammad ;
Lim, Dawith ;
Nolte, David ;
Turek, John ;
Perkins, Susan M. ;
Jalal, Shadia I. .
FRONTIERS IN ONCOLOGY, 2024, 14
[42]   More May Not Be Better: Comparison of Oncologic Outcomes Following Induction Chemotherapy Plus Chemoradiation and Chemoradiation Alone for Esophageal Adenocarcinoma [J].
Yee, Elliott J. ;
Read, Jake ;
Ziogas, Ioannis A. ;
Stuart, Christina M. ;
Olsen, Jeffrey ;
Kim, Sunnie S. ;
Mitchell, John D. ;
Meguid, Robert A. ;
McCarter, Martin D. ;
Mungo, Benedetto .
JOURNAL OF SURGICAL ONCOLOGY, 2025, 131 (04) :598-606
[43]   Cost-effectiveness of neoadjuvant multimodal therapy in patients with esophageal adenocarcinoma [J].
Davini, I ;
Becagli, P ;
Pani, M ;
Trippoli, S ;
Peverini, D ;
Messori, A ;
Carmignani, A .
ONCOLOGY REPORTS, 1997, 4 (05) :1033-1037
[44]   Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma [J].
Thota, Prashanthi N. ;
Alkhayyat, Motasem ;
Cifuentes, Juan D. Gomez ;
Haider, Mahnur ;
Bena, James ;
McMichael, John ;
Sohal, Davender P. ;
Raja, Siva ;
Sanaka, Madhusudhan R. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (02) :125-132
[45]   Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery [J].
Wu, Ya-hua ;
Lin, Ming-qiang ;
Wang, Zhi-ping ;
Li, Jian-cheng .
TRANSLATIONAL ONCOLOGY, 2021, 14 (05)
[46]   Lymphovascular Invasion is an Independent Negative Prognostic Factor in Esophageal Adenocarcinoma [J].
Donato, Britton B. ;
Campany, Megan E. ;
Brady, Justin T. ;
Asher Jenkins, J. ;
Butterfield, Richard ;
Armstrong, Valerie ;
Beamer, Staci E. ;
dos Santos, Pedro Reck ;
D'Cunha, Jonathan .
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) :6680-6690
[47]   Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts [J].
Sawas, Tarek ;
Killcoyne, Sarah ;
Iyer, Prasad G. ;
Wang, Kenneth K. ;
Smyrk, Thomas C. ;
Kisiel, John B. ;
Qin, Yi ;
Ahlquist, David A. ;
Rustgi, Anil K. ;
Costa, Rui J. ;
Gerstung, Moritz ;
Fitzgerald, Rebecca C. ;
Katzka, David A. .
GASTROENTEROLOGY, 2018, 155 (06) :1720-+
[48]   HIF-1α mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer [J].
Ling, Frederike C. ;
Leimbach, Nadine ;
Baldus, Stephan E. ;
Buechel, Sandra ;
Neiss, Susanne ;
Brabender, Jan ;
Drebber, Uta ;
Dienes, Hans P. ;
Mueller, Rolf P. ;
Hoelscher, Arnulf H. ;
Schneider, Paul M. .
ANTICANCER RESEARCH, 2006, 26 (6B) :4505-4509
[49]   The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy [J].
Wayne Croft ;
Richard P. T. Evans ;
Hayden Pearce ;
Mona Elshafie ;
Ewen A. Griffiths ;
Paul Moss .
Molecular Cancer, 21
[50]   The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy [J].
Croft, Wayne ;
Evans, Richard P. T. ;
Pearce, Hayden ;
Elshafie, Mona ;
Griffiths, Ewen A. ;
Moss, Paul .
MOLECULAR CANCER, 2022, 21 (01)
12345